China's WuXi Drug Outsourcer Names New CFO As Revenues Rise
This article was originally published in PharmAsia News
Executive Summary
WuXi Pharma of China has appointed a new CFO, Hao Zhou, as the company reports unexpectedly high quarterly revenue for its drug research outsourcing business